AnHeart Therapeutics
About:
AnHeart Therapeutics is a developer of innovative pharmaceutical products.
Website: http://anhearttherapeutics.com/en/home
Top Investors: Innovent Biologics, Vertex Ventures China, Decheng Capital, Laurion Capital Management, Octagon Capital Advisors
Description:
AnHeart Therapeutics is a developer of innovative pharmaceutical products. The company is focused on acquiring, developing and commercializing innovative pharmaceutical products that improve human health and quality of life. It's main research product, AB-106, is an oral, highly selective ROS1/NTRK small molecule inhibitor.
$75.6M
$10M to $50M
Hangzhou, Zhejiang, China
2018-01-01
BD(AT)anhearttherapeutics.com
Junyuan (Jerry) Wang, Lihua Zheng
51-100
2021-12-14
Private
© 2025 bioDAO.ai